Literature DB >> 34157740

Hyperbaric oxygen treatment for intrauterine limb ischaemia: a newborn in the chamber.

Bengusu Mirasoglu1,2, Hande Cetin1, Sevgi Ozdemir Akgun3, Samil Aktas1.   

Abstract

Intrauterine limb ischaemia is a rare condition that may have devastating results. Various treatments are reported in the literature; however, results are not always promising and amputations may be required for some patients. Post-natal hyperbaric oxygen treatment (HBOT) may be a useful treatment option for the salvage of affected limbs. A patient who was born with total brachial artery occlusion and severe limb ischaemia was referred for HBOT. The patient underwent the first HBOT session at her 48th hour of life. A total of 47 HBOT sessions were completed (243.1 kPa [2.4 atmospheres absolute], duration 115 minutes being: 15 minutes of compression; three 25-minute oxygen periods separated by five-minute air breaks; and 15 minutes of decompression), four in the first 24 hours. Full recovery was achieved with this intense HBOT schedule combined with anticoagulation, fasciotomy and supportive care. The new-born tolerated HBOT well and no complications or side effects occurred. To the best of our knowledge, our patient is one of the youngest patients reported to undergo HBOT. Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.

Entities:  

Keywords:  Case reports; Limb salvage; Neonatal gangrene; Neonatal thromboembolism; Safety

Mesh:

Substances:

Year:  2021        PMID: 34157740      PMCID: PMC8426121          DOI: 10.28920/dhm51.2.220-223

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   1.228


  13 in total

Review 1.  Intrauterine upper limb ischemia associated with fetal thrombophilia: a case report and review of the literature.

Authors:  Wadah M Khriesat; Hala S Al-Rimawi; Isam M Lataifeh; Suleimman Al-Sweedan; Eyad Baqain
Journal:  Acta Haematol       Date:  2010-05-21       Impact factor: 2.195

Review 2.  Hyperbaric oxygen: a useful adjunct for purpura fulminans: case report and review of the literature.

Authors:  Jeffrey S Cooper; Peter Allinson; Lon Keim; Joe Sisson; Dan Schuller; Joe Sippel; David H Kovaleski
Journal:  Undersea Hyperb Med       Date:  2014 Jan-Feb       Impact factor: 0.698

3.  Intrauterine upper extremity thrombosis successfully treated with recombinant tissue plasminogen activator, enoxaparin and collagenase.

Authors:  Sadik Yurttutan; Ramazan Ozdemir; Omer Erdeve; Erhan Calisici; Mehmet Yekta Oncel; Serife Suna Oguz; Ugur Dilmen
Journal:  Acta Haematol       Date:  2012-03-05       Impact factor: 2.195

4.  Results of nonoperative management of acute limb ischemia in infants.

Authors:  S Keisin Wang; Gary W Lemmon; Natalie A Drucker; Raghu L Motaganahalli; Michael C Dalsing; Ashley R Gutwein; Brian W Gray; Michael P Murphy
Journal:  J Vasc Surg       Date:  2017-12-08       Impact factor: 4.268

Review 5.  Hyperbaric oxygen therapy for trauma: crush injury, compartment syndrome, and other acute traumatic peripheral ischemias.

Authors:  R A Myers
Journal:  Int Anesthesiol Clin       Date:  2000

6.  Hyperbaric oxygen in treatment of neonatal arterial thromboembolism of lower extremities.

Authors:  J Wiebers; I Purdy; M Lieber; V Milisavljevic
Journal:  J Perinatol       Date:  2006-12       Impact factor: 2.521

7.  Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo.

Authors:  Tatyana N Milovanova; Veena M Bhopale; Elena M Sorokina; Jonni S Moore; Thomas K Hunt; Martin Hauer-Jensen; Omaida C Velazquez; Stephen R Thom
Journal:  J Appl Physiol (1985)       Date:  2008-11-20

Review 8.  Spontaneous neonatal arterial thromboembolism: infants at risk, diagnosis, treatment, and outcomes.

Authors:  Galit Rashish; Bosco A Paes; Kim Nagel; Anthony K Chan; Sumesh Thomas
Journal:  Blood Coagul Fibrinolysis       Date:  2013-12       Impact factor: 1.276

9.  Hyperbaric oxygenation combined with streptokinase for treatment of arterial thromboembolism of the lower leg.

Authors:  Slobodan Mihaljević; Ljiljana Mihaljević; Visnja Majerić-Kogler; Kresimir Oremus
Journal:  Wien Klin Wochenschr       Date:  2004-02-28       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.